Surgery, Gastroenterology and Oncology
Vol. 23, No. 6, Dec 2018
Prognostic Significance of Lymph Node Ratio After Resection of Peri-hilar Cholangiocarcinoma
Alfredo Guglielmi, Andrea Ruzzenete, Fabio Bagante, Tommaso Campagnaro, Simone Conci, Calogero Iacono
REVIEW, Dec 2018
Article DOI: 10.21614/sgo-23-6-373
Even though lymph node status is one of the most important predictors of survival for patients undergoing curative-intent surgery for peri-hilar cholangiocarcinoma (PHCC), the optimal lymph node staging system for PHCC has not been identified.
Recently, the newly published 8th edition of the American Joint Committee on Cancer (AJCC) staging system reformed the criteria used to stage the lymph node status of PHCC patients but this change did not demonstrate to significantly improve the prognostic stratification of patients with PHCC. Among the several clinical tools that have been proposed in replacement of the AJCC N stages, the lymph node ratio (LNR) defined as the ratio of the number of metastatic lymph nodes to the number of lymph nodes harvested, demonstrated to improve the lymph node staging of patients with several gastrointestinal and hepatobiliary cancers.
When tested in PHCC patients, while LNR was associated with patientsâ?? prognosis, the prognostic performances of LNR were strongly influenced by the number of lymph node harvested suggesting that LNR might be of less clinical value in PHCC patients due to the relatively small number of lymph node harvested compared with other gastrointestinal cancers.
While other clinical tool (i.e. LODDS) has been proposed to assess lymph node status, further studies are needed to improve the lymph nodal staging of PHCC patients.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 2731


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Dec 2024

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/